Lung cancer, Small cell lung cancer
Results
Other
This study looked at biomarkers in tissue samples, and in the blood of people with small cell cancer. A biomarker is a substance in the body that doctors can measure, which helps them tell how a disease is developing or a treatment is working. This study was supported by Cancer Research UK.
Genes are coded messages that tell a cell how to behave and grow. Doctors may use certain genes or proteins in cancer cells as biomarkers.
Small cell cancer is called ‘small cell’ because under a microscope the cells appear small. It most often affects the lungs (small cell lung cancer), but can also start in other parts of the body such as the food pipe (oesophagus) or the cervix.
In this study, the researchers wanted to look at the biomarkers in small cell cancer to see if they could help them to
Decide which treatments to use
Work out why treatment sometimes doesn’t work
Develop new treatments
Recruitment start: 1 August 2006
Recruitment end: 15 July 2011
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Fiona Blackhall
Cancer Research UK
European Union FP7
Experimental Cancer Medicine Centre (ECMC)
The Christie Lung Cancer Research Fund
Last reviewed: 15 Mar 2013
CRUK internal database number: 1254
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
